Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017

Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017


  • Products Id :- GDME0344EPD
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2017" provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Implantable Infusion Pumps under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Implantable Infusion Pumps under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Implantable Infusion Pumps Overview 6

3 Products under Development 7

3.1 Implantable Infusion Pumps-Pipeline Products by Stage of Development 7

3.2 Implantable Infusion Pumps-Pipeline Products by Territory 8

3.3 Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9

3.4 Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10

3.5 Implantable Infusion Pumps-Ongoing Clinical Trials 11

4 Implantable Infusion Pumps-Pipeline Products under Development by Companies 12

4.1 Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 12

4.2 Implantable Infusion Pumps-Pipeline Products by Stage of Development 13

5 Implantable Infusion Pumps Companies and Product Overview 14

5.1 Alnylam Pharmaceuticals Inc Company Overview 14

5.1.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Debiotech SA Company Overview 15

5.2.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Eksigent Technologies LLC Company Overview 17

5.3.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Eli Lilly and Company Company Overview 18

5.4.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Flowonix Medical Inc Company Overview 19

5.5.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 FluidSynchrony, LLC Company Overview 23

5.6.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 Intarcia Therapeutics Inc Company Overview 24

5.7.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Medallion Therapeutics, Inc. Company Overview 26

5.8.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Nano Precision Medical Inc Company Overview 27

5.9.1 Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 University of Minnesota Company Overview 28

5.10.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 28

5.11 University of Southern California Company Overview 29

5.11.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 29

6 Implantable Infusion Pumps- Recent Developments 30

6.1 Mar 14, 2017: Medtronic Announces Class I Recall for SynchroMed II Implantable Drug Infusion Pump 30

6.2 Mar 14, 2017: Medtronic Announces Class I Recall For SynchroMed EL Implantable Drug Infusion Pumps 30

6.3 Mar 14, 2017: Flowonix Medical And Cerebral Therapeutics Announce World-First Clinical Trial Delivering Medication Directly Into The Brain For Patients With Refractory Epilepsy 31

6.4 Feb 03, 2017: Intarcia Announces FDA Filing Acceptance of New Drug Application for ITCA 650 for the Treatment of Type 2 Diabetes 32

6.5 Oct 28, 2016: Teleflex Incorporated Signs New Agreement with Premier for Implantable Infusion Ports 32

6.6 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 32

7 Appendix 35

7.1 Methodology 35

7.2 About GlobalData 38

7.3 Contact Us 38

7.4 Disclaimer 38

1.2 List of Figures

Figure 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 7

Figure 2: Implantable Infusion Pumps-Pipeline Products by Territory 8

Figure 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9

Figure 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10

Figure 5: Implantable Infusion Pumps-Ongoing Clinical Trials 11

1.1 List of Tables

Table 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 7

Table 2: Implantable Infusion Pumps-Pipeline Products by Territory 8

Table 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 9

Table 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 10

Table 5: Implantable Infusion Pumps-Ongoing Clinical Trials 11

Table 6: Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 12

Table 7: Implantable Infusion Pumps-Pipeline Products by Stage of Development 13

Table 8: Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: ALN-HTT Infusion System-Product Status 14

Table 10: ALN-HTT Infusion System-Product Description 14

Table 11: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 15

Table 12: MIP Device-Product Status 15

Table 13: MIP Device-Product Description 16

Table 14: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: Implantable Drug Delivery System-Product Status 17

Table 16: Implantable Drug Delivery System-Product Description 17

Table 17: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: Drug Delivery System-Parkinson's Disease-Product Status 18

Table 19: Drug Delivery System-Parkinson's Disease-Product Description 18

Table 20: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 21: Implanted Drug Delivery System-Product Status 19

Table 22: Implanted Drug Delivery System-Product Description 19

Table 23: Prometra II Programmable Infusion System-Product Status 20

Table 24: Prometra II Programmable Infusion System-Product Description 20

Table 25: Flowonix Medical Inc-Ongoing Clinical Trials Overview 21

Table 26: Prometra II Programmable Infusion System-A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization 22

Table 27: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Table 28: FluidSync Pump-Product Status 23

Table 29: FluidSync Pump-Product Description 23

Table 30: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 24

Table 31: ITCA 650 Osmotic Pump-Product Status 24

Table 32: ITCA 650 Osmotic Pump-Product Description 25

Table 33: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 34: Medallion Infusion System-Product Status 26

Table 35: Medallion Infusion System-Product Description 26

Table 36: Nano Precision Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 37: Nano Portal Capsule-Product Status 27

Table 38: Nano Portal Capsule-Product Description 27

Table 39: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 28

Table 40: Infusion Micropump-Product Status 28

Table 41: Infusion Micropump-Product Description 28

Table 42: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 29

Table 43: Drug Infusion Pump-Product Status 29

Table 44: Drug Infusion Pump-Product Description 29

Table 45: Glossary 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Alnylam Pharmaceuticals Inc, Debiotech SA, Eksigent Technologies LLC, Eli Lilly and Company, Flowonix Medical Inc, FluidSynchrony, LLC, Intarcia Therapeutics Inc, Medallion Therapeutics, Inc., Nano Precision Medical Inc, University of Minnesota, University of Southern California

Alnylam Pharmaceuticals Inc, ALN-HTT Infusion System; Debiotech SA, MIP Device; Eksigent Technologies LLC, Implantable Drug Delivery System; Eli Lilly and Company, Drug Delivery System-Parkinson's Disease; Flowonix Medical Inc, Implanted Drug Delivery System; Flowonix Medical Inc, Prometra II Programmable Infusion System; FluidSynchrony, LLC, FluidSync Pump; Intarcia Therapeutics Inc, ITCA 650 Osmotic Pump; Medallion Therapeutics, Inc., Medallion Infusion System; Nano Precision Medical Inc, Nano Portal Capsule; University of Minnesota, Infusion Micropump; University of Southern California, Drug Infusion Pump

select a license

Single User License
USD 2500 INR 161425
Site License
USD 5000 INR 322850
Corporate User License
USD 7500 INR 484275

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com